Array Technologies (ARRY) sinks 7.2% in Friday's trading as UBS downgraded the solar tracking manufacturer to Neutral from Buy with a $5 price target, slashed from $10, as the bank expects the use of ...
Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 ...
Narmi and Array represent a new wave of technology providers reshaping the financial services landscape. With a modern API architecture, flexible integrations, and a shared focus on financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results